Moloney Securities Asset Management LLC lessened its position in Roche Holding AG (OTCMKTS:RHHBY – Free Report) by 7.2% during the third quarter, according to the company in its most recent 13F filing with the SEC. The fund owned 27,218 shares of the company’s stock after selling 2,100 shares during the quarter. Moloney Securities Asset Management LLC’s holdings in Roche were worth $1,091,000 as of its most recent filing with the SEC.
A number of other hedge funds and other institutional investors have also bought and sold shares of the company. AlphaMark Advisors LLC bought a new position in Roche in the third quarter valued at approximately $149,000. GAMMA Investing LLC boosted its stake in shares of Roche by 61.5% during the 2nd quarter. GAMMA Investing LLC now owns 5,038 shares of the company’s stock worth $175,000 after acquiring an additional 1,919 shares during the period. Archer Investment Corp boosted its stake in shares of Roche by 10.6% during the 2nd quarter. Archer Investment Corp now owns 6,810 shares of the company’s stock worth $236,000 after acquiring an additional 652 shares during the period. Waldron Private Wealth LLC bought a new position in shares of Roche during the 2nd quarter worth approximately $263,000. Finally, Lee Danner & Bass Inc. bought a new position in shares of Roche during the 2nd quarter worth approximately $327,000.
Analyst Upgrades and Downgrades
Several research analysts have recently commented on the company. Deutsche Bank Aktiengesellschaft downgraded Roche from a “hold” rating to a “sell” rating in a research note on Friday, September 13th. Bank of America upgraded Roche from a “neutral” rating to a “buy” rating in a research note on Friday, September 13th. Three investment analysts have rated the stock with a sell rating, one has issued a hold rating and one has assigned a buy rating to the company’s stock. Based on data from MarketBeat, the stock currently has a consensus rating of “Hold”.
Roche Stock Performance
RHHBY opened at $38.91 on Wednesday. The business has a fifty day simple moving average of $39.63 and a 200 day simple moving average of $36.79. Roche Holding AG has a 1 year low of $29.20 and a 1 year high of $42.43.
Roche Profile
Roche Holding AG engages in the pharmaceuticals and diagnostics businesses in Europe, North America, Latin America, Asia, Africa, Australia, and Oceania. The company offers pharmaceutical products in the therapeutic areas of anemia, blood and solid tumors, dermatology, hemophilia, inflammatory and autoimmune, neurological disorders, ophthalmology, respiratory disorders, and transplantation.
See Also
- Five stocks we like better than Roche
- Best Stocks Under $5.00
- Palantir Cracks $50, Is There Still Time to Get on Board?
- Quiet Period Expirations Explained
- Insider Buying Signals Upside for These 3 Stocks
- Should You Add These Warren Buffett Stocks to Your Portfolio?
- These 2 Big Players Are Set to Compete With Elon Musk’s Starlink
Want to see what other hedge funds are holding RHHBY? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Roche Holding AG (OTCMKTS:RHHBY – Free Report).
Receive News & Ratings for Roche Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Roche and related companies with MarketBeat.com's FREE daily email newsletter.